BlackRock Investment Management’s Repros Therapeutics Inc. RPRX Stock Holding History

BlackRock Investment Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5K	Hold	3,757	–	–	﹤0.01%	3786
2016 Q3	$8K	Sell	3,757 -567	-13%	-$1.12K	﹤0.01%	3692
2016 Q2	$7K	Hold	4,324	–	–	﹤0.01%	3794
2016 Q1	$4K	Hold	4,324	–	–	﹤0.01%	3896
2015 Q4	$5K	Buy	4,324 +116	+3%	+$372	﹤0.01%	3899
2015 Q3	$31K	Buy	4,208 +207	+5%	+$1.58K	﹤0.01%	3356
2015 Q2	$29K	Sell	4,001 -66,861	-94%	-$521K	﹤0.01%	3361
2015 Q1	$609K	Buy	70,862 +716	+1%	+$6.4K	﹤0.01%	2853
2014 Q4	$699K	Buy	70,146 +1,935	+3%	+$16.5K	﹤0.01%	2798
2014 Q3	$675K	Buy	68,211 +635	+0.9%	+$9.4K	﹤0.01%	2792
2014 Q2	$1.17M	Buy	67,576 +3,884	+6%	+$63.3K	﹤0.01%	2488
2014 Q1	$1.13M	Buy	63,692 +854	+1%	+$16.5K	﹤0.01%	2424
2013 Q4	$1.15M	Sell	62,838 -1,231	-2%	-$23.2K	﹤0.01%	2415
2013 Q3	$1.72M	Buy	64,069 +14,128	+28%	+$303K	﹤0.01%	2062
2013 Q2	$921K	Buy	+49,941	New	+$882K	﹤0.01%	2424

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Investment Management's RPRX Position: Q4 2016 in Review

BlackRock Investment Management held its Repros Therapeutics Inc. (RPRX) position steady in Q4 2016 at 3,757 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #3786.

BlackRock Investment Management first reported a position in RPRX in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.72M in Q3 2013. 43 funds tracked by Wall St. Rank hold RPRX as of Q4 2016.

BlackRock Investment Management held 3,757 shares of Repros Therapeutics Inc. worth $5K as of Q4 2016.
BlackRock Investment Management left its Repros Therapeutics Inc. share count unchanged in Q4 2016.
Repros Therapeutics Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3786 holding.
BlackRock Investment Management first reported a position in Repros Therapeutics Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Repros Therapeutics Inc. position peaked at $1.72M in Q3 2013.
43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.